Why It Matters
Beijing has simultaneously tightened export controls and rolled out new incentives for foreign investment in the same week — a dual signal that your business strategy needs to account for. This is not the first time China has recalibrated its foreign investment framework in 2026: in early July, the government published a comprehensive package of sci-tech investment incentives for foreign firms, signaling that while certain technology transfers face new scrutiny, capital is still welcome in priority sectors.
These are not contradictory moves. They reflect Beijing’s calibrated approach: protect strategic technologies while welcoming foreign capital that brings R&D, supply chain integration, and clean-tech knowhow. For foreign businesses, the line between restricted and encouraged sectors is sharper than ever — and getting it wrong has real consequences.
The Details
The export ban targets 10 U.S. entities involved in advanced semiconductors, aerospace components, and military-adjacent technologies. Caixin reported that the list includes both major defense contractors and specialized electronics firms. The restriction covers all dual-use items — goods and technologies that have both civilian and military applications — and builds on a pattern of escalating tech export controls that has accelerated since 2022. The week also saw China ban helium exports amid a global supply crunch affecting chip manufacturing, and step up enforcement of critical mineral export controls — a coordinated tightening of resource and technology outflows.
Separately, the State Council’s new Foreign Investment Action Plan introduces several concrete measures. According to China Briefing’s analysis, the plan prioritizes foreign investment in sci-tech enterprises by streamlining approval for R&D centers, extending tax holidays for qualifying foreign-invested technology firms, and creating dedicated service windows for foreign tech companies in 20 pilot cities.
The plan also commits to expanding the Catalog of Encouraged Industries for Foreign Investment (鼓励外商投资产业目录, gǔlì wàishāng tóuzī chǎnyè mùlù), which already lists over 1,200 sub-categories. New additions are expected in biopharmaceuticals, new energy materials, and industrial software.
Data from MOFCOM shows foreign direct investment (FDI) into China’s high-tech manufacturing sector grew 11.2% year-on-year in the first half of 2026, reaching $21.4 billion — even as overall FDI into China contracted 3.8% over the same period. The divergence underscores where the real opportunity sits. Complementing the investment plan, the Tianjin Free Trade Zone released China’s first negative list for cross-border data transfer — a parallel initiative aimed at reducing compliance uncertainty for foreign tech firms navigating China’s data security framework.
What You Should Do
First, audit your supply chain for any exposure to the restricted entities list. If your China operations purchase components or software from any of the 10 named U.S. entities, you may need to find alternative suppliers within 90 days — the grace period for existing contracts under the new rules.
Second, if your business operates in biopharma, clean energy, or industrial software, review whether your China entity qualifies for the new sci-tech incentives. The streamlined R&D center approval process can cut setup time from 6 months to under 60 days in pilot cities like Shanghai, Beijing, and Shenzhen.
Third, work with your China legal counsel to confirm your classification under the updated encouraged industries catalog once published. A correct classification can mean the difference between a 15% corporate income tax rate and the standard 25%.
One Data Point
The number to remember: $21.4 billion — that’s FDI into China’s high-tech manufacturing in H1 2026, up 11.2% year-on-year despite a 3.8% overall FDI decline. The market for advanced technologies in China is open — but the door is narrower and the entry requirements are higher than ever. To navigate these dual tracks, review our full guide on China tax incentives for foreign investors — seven programs that can directly offset the compliance costs of the new regulatory environment.
— China Gateway 360 —
Remote China market entry support, built around execution.
